Key result
Long-term cardiac contractility modulation significantly improved left ventricular ejection fraction by an estimated mean of 4.9% at 24 months in patients with heart failure.
Why the study?
Does cardiac contractility modulation (CCM) improve symptoms, quality of life, and left ventricular ejection fraction in patients with heart failure and reduced ejection fraction?
Population
143 subjects with heart failure and reduced ejection fraction on stable guideline-directed medical therapy…
Design
Cohort
Follow-up
24 months
Authors
Loading...
Supports the potential for sustained functional benefits with device therapy in heart failure; leaves open.
Observational (n=143)
Yes
Does cardiac contractility modulation (CCM) improve symptoms, quality of life, and left ventricular ejection fraction in patients with heart failure and reduced ejection fraction?
Mean Difference: 4.9
p-value: p=<0.001
Long-term cardiac contractility modulation provides sustained symptomatic and functional improvement in heart failure patients over 2 years, independent of baseline LVEF being above or below 35%.
Remppis et al. (2017) conducted an observational in Heart failure with reduced ejection fraction (n=143). Cardiac contractility modulation (CCM) vs. Baseline (no control group) was evaluated on Change in left ventricular ejection fraction at 24 months (4.9% mean improvement, p=<0.001). Long-term cardiac contractility modulation significantly improved left ventricular ejection fraction by an estimated mean of 4.9% at 24 months in patients with heart failure.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: